Showing results (501-510 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|July 23, 2014
Discovery of a Negative Allosteric Modulator of GABAB ReceptorsLin-Hai Chen, Bing Sun, Yang Zhang, et al.ACS Medicinal Chemistry Letters|July 23, 2014
Synthesis and Pharmacological Evaluation of DHβE Analogues as Neuronal Nicotinic Acetylcholine Receptor AntagonistsTue Heesgaard Jepsen, Anders A Jensen, Mads Henrik Lund, et al.ACS Medicinal Chemistry Letters|July 23, 2014
Bioreductively Activated Reactive Oxygen Species (ROS) Generators as MRSA InhibitorsVinayak S Khodade, Mallojjala Sharath Chandra, Ankita Banerjee, et al.ACS Medicinal Chemistry Letters|July 23, 2014
Enhanced Cytotoxicity through Conjugation of a "Clickable" Luminescent Re(I) Complex to a Cell-Penetrating LipopeptideAnna Leonidova, Vanessa Pierroz, Luke A Adams, et al.ACS Medicinal Chemistry Letters|December 14, 2011
Monoenomycin: A Simplified Trienomycin A Analogue that Manifests Anticancer ActivityGary E L Brandt, Brian S J BlaggACS Medicinal Chemistry Letters|December 21, 2012
A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent CellsMichel Weïwer, James Spoonamore, Jingqiang Wei, et al.ACS Medicinal Chemistry Letters|January 1, 2013
Novel bivalent ligands for D2/D3 dopamine receptors: Significant co-operative gain in D2 affinity and potencySanjib Gogoi, Swati Biswas, Gyan Modi, et al.ACS Medicinal Chemistry Letters|August 10, 2013
Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and Nanomolar Activity Against Mycobacterium tuberculosis.Garrett C Moraski, Lowell D Markley, Jeffrey Cramer, et al.ACS Medicinal Chemistry Letters|July 13, 2013
Discovery and Preliminary SAR of Arylpiperazines as Novel, Brainpenetrant Antiprion CompoundsZhe Li, Joel Gever, Satish Rao, et al.ACS Medicinal Chemistry Letters|April 9, 2013
The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic CleftPeter Silhár, Matthew A Lardy, Mark S Hixon, et al.Pageof 438